Navigation Links
Researchers & Department of Defense Question Multiple Vaccine Administration
Date:12/4/2008

SafeMinds Asks, "Is Mercury a Common Factor?"

WASHINGTON, Dec. 4 /PRNewswire-USNewswire/ -- Two new reports announced last week call into question the safety of the Centers for Disease Control (CDC) decade's old policy of routinely administering multiple vaccines concurrently.

Mitochondrial Disease in Autism Spectrum Disorder Patients, published last week in PLOS One by investigators from the Cleveland Clinic, Johns Hopkins Kennedy Krieger Institute and Massachusetts General Hospital concluded that disturbance in mitochondria (energy production cells) is an underlying mechanism in a subset of individuals with autism. "There might be no difference between the inflammatory or catabolic stress of vaccinations and that of common childhood diseases" they said, and "large, population-based studies will be needed to identify a possible relationship of vaccination with autistic regression in persons with mitochondrial cytopathies."

In a November 26th response to Congresswoman Carolyn Maloney concerning adverse vaccine events, Colonel Renata Engler of the DOD Vaccine Healthcare Center commented on their collaboration with the CDC, "We have preliminary findings from one of our many on-going research studies that suggest a relationship between adverse events and multiple vaccinations exist." She added, "The recommendation for more research on subpopulation risk factors in relation to multiple vaccine combinations has been included in the Institute of Medicine (IOM) Report on Multiple Vaccines."

Regarding findings by Elliott and colleagues in August, the United Mitochondrial Disease Foundation stated that mitochondrial disorder is likely to be at the core of many health conditions including autism. These latest findings provide additional evidence that the link between autism and mitochondrial disorders is not "rare," as government officials characterized it after the Poling family was recently compensated for their daughter's vaccine injury.

SafeMinds Vice President Lyn Redwood stated, "Research clearly demonstrates that mercury in vaccines causes mitochondrial damage, yet mercury-containing vaccines continue to be administered to infants and pregnant women despite the IOM's recommendation that these populations not be exposed." SafeMinds believes the government should initiate a comprehensive study of vaccinated/unvaccinated populations examining all health outcomes, vaccine components and synergistic interactions.

Environmental mercury exposure has also been linked to mental retardation, Attention Deficit Disorder and autism. SafeMinds President Theresa Wrangham added, "Mercury in all forms is neurotoxic and is increasingly impacting public health. Congressional action is needed to shift industry from its use in medicine, utilities and consumer products."

View mercury/mitochondrial research at

www.safeminds.org/research/science-autism-mitochondria-mercury.html


'/>"/>
SOURCE SafeMinds
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
4. Bipolar disorder relapses halved by Melbourne researchers
5. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
6. High and mighty: first common height gene identified by researchers behind obesity gene finding
7. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
8. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
9. Researchers develop long-lasting growth hormone
10. Jefferson immunology researchers halt lethal rabies infection in brain
11. Purdue researchers develop technology to detect cancer by scanning surface veins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... The ... consultations to communities in the greater Denver region, is announcing a charity drive ... a very rare kind of epilepsy. , Until a few months ago, Dominik ...
(Date:7/21/2017)... ... July 21, 2017 , ... The Karen ... services to communities in the greater Birmingham area, is joining the Chris Hammond ... young people in the region. , The Chris Hammond Youth Foundation maintains athletic ...
(Date:7/21/2017)... PHILADELPHIA (PRWEB) , ... July 21, 2017 , ... ... ARTZ Philadelphia and Theater of Witness , was awarded a $300,000 ... growing humanities program which fosters empathy, comfort with ambiguity and the recognition of ...
(Date:7/21/2017)... ... July 21, 2017 , ... The Margarian Law Firm has filed a ... its ginger ale for allegedly containing no ginger. Dr. Pepper produces the “Canada Dry” ... plaintiff Gegham Margaryan alleges Canada Dry Ginger Ale claims on its bottle that it ...
(Date:7/21/2017)... , ... July 21, 2017 , ... ... medical students improve their chances of acceptance to a residency in a United ... have earned degrees outside the U.S. , According to data released by the ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... Md. , July 13, 2017  New York City-based ... of pharmaceutical markets should be aware of.  From new products ... trends are detailed in a recently completed study, Potential ... 1.  Age-Driven Growth ... we have been aware of the impact the growing population ...
(Date:7/11/2017)...  Bayer has awarded grants totaling more than $2 million ... prestigious Bayer Hemophilia Awards Program (BHAP). Four U.S. clinicians and ... and Uniformed Services University of the Health Sciences in ... recipients were announced last night during a reception at the ... Berlin, Germany . ...
(Date:7/11/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... the development of oral drug delivery systems, announced today ... agreed to schedule an End-of-Phase II meeting with Oramed ... oral insulin capsule ORMD-0801 in the treatment of type ... secondary endpoints by indicating a statistically significant lowering of ...
Breaking Medicine Technology: